|
ATE146783T1
(de)
*
|
1991-11-01 |
1997-01-15 |
Upjohn Co |
Substituierte aryl- und heteroaryl- phenyloxazolidinone
|
|
US5688792A
(en)
*
|
1994-08-16 |
1997-11-18 |
Pharmacia & Upjohn Company |
Substituted oxazine and thiazine oxazolidinone antimicrobials
|
|
MY115155A
(en)
*
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
|
WO1995014684A1
(en)
*
|
1993-11-22 |
1995-06-01 |
The Upjohn Company |
Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
|
|
JPH0873455A
(ja)
*
|
1994-03-15 |
1996-03-19 |
Upjohn Co:The |
オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
|
|
US5668286A
(en)
*
|
1994-03-15 |
1997-09-16 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions containing them
|
|
DE4425613A1
(de)
*
|
1994-07-20 |
1996-01-25 |
Bayer Ag |
5-gliedrige Heteroaryl-oxazolidinone
|
|
DE4425612A1
(de)
*
|
1994-07-20 |
1996-04-04 |
Bayer Ag |
6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
|
|
DE19514313A1
(de)
*
|
1994-08-03 |
1996-02-08 |
Bayer Ag |
Benzoxazolyl- und Benzothiazolyloxazolidinone
|
|
SK282869B6
(sk)
*
|
1994-10-26 |
2003-01-09 |
Pharmacia + Upjohn Company |
Antimikrobiálne fenyloxazolidinóny
|
|
NZ295528A
(en)
*
|
1994-11-15 |
1999-03-29 |
Upjohn Co |
Bicyclic oxazine and thiazine oxazolidinone antibacterials
|
|
CA2208603A1
(en)
*
|
1995-02-03 |
1996-08-08 |
The Upjohn Company |
Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
|
|
ES2162047T3
(es)
*
|
1995-05-11 |
2001-12-16 |
Upjohn Co |
Oxazolidinonas con resto diazinilo y carbazinilo espirociclico y biciclico.
|
|
CN1072222C
(zh)
*
|
1995-09-01 |
2001-10-03 |
法玛西雅厄普约翰公司 |
以c-c键连接于4-8元杂环环的苯基噁唑烷酮
|
|
MX9703040A
(es)
*
|
1995-09-12 |
1997-07-31 |
Upjohn Co |
Antimicrobianos de feniloxazolidinona.
|
|
GB9521508D0
(en)
*
|
1995-10-20 |
1995-12-20 |
Zeneca Ltd |
Chemical compounds
|
|
ZA969622B
(en)
*
|
1995-12-13 |
1998-05-15 |
Upjohn Co |
Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
|
|
GB9601666D0
(en)
*
|
1996-01-27 |
1996-03-27 |
Zeneca Ltd |
Chemical compounds
|
|
HRP970049A2
(en)
*
|
1996-02-06 |
1998-04-30 |
Bayer Ag |
New heteroaryl oxazolidinones
|
|
GB9702213D0
(en)
|
1996-02-24 |
1997-03-26 |
Zeneca Ltd |
Chemical compounds
|
|
GB9604301D0
(en)
*
|
1996-02-29 |
1996-05-01 |
Zeneca Ltd |
Chemical compounds
|
|
ATE209193T1
(de)
*
|
1996-04-11 |
2001-12-15 |
Upjohn Co |
Verfahren zur herstellung von oxazolidinonen
|
|
GB9609919D0
(en)
|
1996-05-11 |
1996-07-17 |
Zeneca Ltd |
Chemical compounds
|
|
GB9614236D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
|
GB9614238D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
|
US6037354A
(en)
|
1997-06-18 |
2000-03-14 |
Merck & Co., Inc. |
Alpha 1a adrenergic receptor antagonists
|
|
JP2002513424A
(ja)
*
|
1997-07-11 |
2002-05-08 |
ファルマシア・アンド・アップジョン・カンパニー |
チアジアゾリルおよびオキサジアゾリルフェニルオキサゾリジノン抗菌剤
|
|
DE19730847A1
(de)
*
|
1997-07-18 |
1999-01-28 |
Bayer Ag |
Tricyclisch substituierte Oxazolidinone
|
|
GB9717807D0
(en)
*
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
|
EE04370B1
(et)
|
1997-11-07 |
2004-10-15 |
Pharmacia & Upjohn Company |
Oksasolidinoonide valmistamismeetod, meetodis kasutatavad vaheühendid ja nende valmistamine
|
|
CA2303959A1
(en)
*
|
1997-11-12 |
1999-05-20 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions
|
|
PT1032386E
(pt)
*
|
1997-11-18 |
2003-07-31 |
Upjohn Co |
Utilizacao de derivados da oxazolidinona para o tratamento de artrites
|
|
DK1304107T3
(da)
*
|
1997-11-18 |
2005-08-22 |
Pharmacia & Upjohn Co Llc |
Anvendelse af oxozolidinonderivater til behandling af psoriasis
|
|
US6040306A
(en)
*
|
1997-11-18 |
2000-03-21 |
Pharmacia & Upjohn Company |
Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
|
GB9725244D0
(en)
|
1997-11-29 |
1998-01-28 |
Zeneca Ltd |
Chemical compounds
|
|
US6083967A
(en)
*
|
1997-12-05 |
2000-07-04 |
Pharmacia & Upjohn Company |
S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones
|
|
AU1694099A
(en)
*
|
1997-12-26 |
1999-07-19 |
Cheil Jedang Corporation |
Cephem derivatives and a method for producing the compounds and an antibacterialcomposition containing the compounds
|
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
|
US6239152B1
(en)
|
1998-01-23 |
2001-05-29 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
|
CN1311787A
(zh)
|
1998-06-05 |
2001-09-05 |
阿斯特拉曾尼卡有限公司 |
噁唑烷酮衍生物、其制备方法以及含有它们的药物组合物
|
|
MY122454A
(en)
*
|
1998-06-05 |
2006-04-29 |
Upjohn Co |
Use of oxazolidinones for the preparation of a medicament for transdermal delivery
|
|
CA2334811A1
(en)
*
|
1998-07-14 |
2000-01-27 |
Pharmacia & Upjohn Company |
Oxazolidinones to treat eye infections
|
|
AU1379900A
(en)
*
|
1998-11-17 |
2000-06-05 |
Bayer Aktiengesellschaft |
Novel substituted phenyloxazolidone derivatives
|
|
AU4224699A
(en)
|
1999-01-27 |
2000-08-18 |
Pharmacia & Upjohn Company |
Assays for modulators of elongation factor p activity
|
|
US6608081B2
(en)
|
1999-08-12 |
2003-08-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
|
|
US6413981B1
(en)
|
1999-08-12 |
2002-07-02 |
Ortho-Mcneil Pharamceutical, Inc. |
Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
|
|
US6297242B1
(en)
|
1999-08-12 |
2001-10-02 |
Ortho-Mcneil Pharmaceutical, Inc. |
N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof
|
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
|
KR100638288B1
(ko)
*
|
1999-12-15 |
2006-10-25 |
동아제약주식회사 |
옥사졸리디논 유도체 및 그 제조방법
|
|
US6518285B2
(en)
|
1999-12-21 |
2003-02-11 |
Ortho Mcneil Pharmaceutical, Inc. |
Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
|
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
|
JP2003535860A
(ja)
|
2000-06-05 |
2003-12-02 |
ドン・ア・ファーム・カンパニー・リミテッド |
新規なオキサゾリジノン誘導体及びその製造方法
|
|
KR100731469B1
(ko)
*
|
2000-06-05 |
2007-06-21 |
동아제약주식회사 |
피리딘 고리를 포함하는 옥사졸리디논 유도체 및 그의제조방법
|
|
KR100713170B1
(ko)
*
|
2001-03-07 |
2007-05-02 |
동아제약주식회사 |
헤테로고리 또는 헤테로아로마틱 고리가 치환된 피리딘고리를 포함하는 옥사졸리디논 유도체 및 그의 제조방법
|
|
KR100674096B1
(ko)
*
|
2000-06-05 |
2007-01-26 |
동아제약주식회사 |
피리미딘 고리를 포함하는 신규 옥사졸리디논 유도체와그의 제조방법
|
|
AU6937001A
(en)
|
2000-07-17 |
2002-01-30 |
Ranbaxy Lab Ltd |
Oxazolidinone derivatives as antimicrobials
|
|
PE20020300A1
(es)
*
|
2000-08-22 |
2002-05-10 |
Pharmacia Corp |
Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
|
|
US6410728B1
(en)
*
|
2000-08-31 |
2002-06-25 |
Abbott Laboratories |
Oxazolidinone chemotherapeutic agents
|
|
US6277868B1
(en)
*
|
2000-08-31 |
2001-08-21 |
Abbott Laboratories |
Oxazolidinone chemotherapeutic agents
|
|
WO2002020515A1
(en)
*
|
2000-09-08 |
2002-03-14 |
Abbott Laboratories |
Oxazolidinone antibacterial agents
|
|
AR031135A1
(es)
|
2000-10-10 |
2003-09-10 |
Upjohn Co |
Composiciones de antibiotico topico para el tratamiento de infecciones oculares
|
|
AU2002224421A1
(en)
|
2000-10-17 |
2002-04-29 |
Pharmacia And Upjohn Company |
Methods of producing oxazolidinone compounds
|
|
US6861433B2
(en)
|
2000-12-15 |
2005-03-01 |
Pharmacia & Upjohn Company |
Oxazolidinone photoaffinity probes
|
|
ATE319710T1
(de)
|
2000-12-21 |
2006-03-15 |
Pharmacia & Upjohn Co Llc |
Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
|
|
CA2405532A1
(en)
*
|
2001-02-07 |
2002-08-22 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
|
|
US6897230B2
(en)
*
|
2001-04-17 |
2005-05-24 |
Kyorin Pharmaceutical Co., Ltd. |
Bicyclo[3/1/0] hexane containing oxazolidinone antibiotics and derivatives thereof
|
|
DE10129725A1
(de)
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
|
US6956040B2
(en)
|
2001-07-16 |
2005-10-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone piperazinyl derivatives as potential antimicrobials
|
|
US7125568B2
(en)
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
|
WO2003031443A1
(de)
*
|
2001-10-04 |
2003-04-17 |
Morphochem Aktiengesellschaft für kombinatorische Chemie |
Dual action antibiotics
|
|
WO2003031441A1
(en)
*
|
2001-10-04 |
2003-04-17 |
Morphochen Aktiengesellschaft Für Kombinatorische Chemie |
Multiple action compounds
|
|
JP2003192773A
(ja)
*
|
2001-12-26 |
2003-07-09 |
Mitsui Chemicals Inc |
生体吸収性ポリヒドロキシカルボン酸及びその製造法
|
|
TW200302095A
(en)
*
|
2002-01-25 |
2003-08-01 |
Upjohn Co |
Oxazolidinone cotherapy
|
|
JP2005519931A
(ja)
*
|
2002-02-05 |
2005-07-07 |
ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー |
細菌感染症治療に有用な抗微生物性チアジアジノン誘導体
|
|
MXPA04008173A
(es)
*
|
2002-02-22 |
2004-11-26 |
Pharmacia Corp |
Formulaciones de farmaco antibiotico oftalmico que contienen un compuesto de ciclodextrina y cloruro de cetil piridinio.
|
|
US7141588B2
(en)
*
|
2002-02-25 |
2006-11-28 |
Pfizer, Inc. |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
|
AR038536A1
(es)
*
|
2002-02-25 |
2005-01-19 |
Upjohn Co |
N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
|
|
IL164195A0
(en)
*
|
2002-03-29 |
2005-12-18 |
Upjohn Co |
Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
|
|
DE60304360T2
(de)
*
|
2002-08-12 |
2006-11-16 |
Pharmacia & Upjohn Co. Llc, Kalamazoo |
N-aryl-2-oxazolidinone und deren derivate
|
|
WO2004026848A1
(en)
*
|
2002-09-20 |
2004-04-01 |
Lupin Limited |
Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
|
|
US7141570B2
(en)
*
|
2002-11-21 |
2006-11-28 |
Pharmacia & Upjohn Company |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
|
GB0229521D0
(en)
*
|
2002-12-19 |
2003-01-22 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0229526D0
(en)
*
|
2002-12-19 |
2003-01-22 |
Astrazeneca Ab |
Chemical compounds
|
|
DE10300111A1
(de)
*
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
|
US20040170686A1
(en)
*
|
2003-01-31 |
2004-09-02 |
Fredrickson Jennifer K. |
Suspension vehicle for coated drug particles
|
|
JP2006516991A
(ja)
*
|
2003-02-07 |
2006-07-13 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
抗菌剤
|
|
TW200500360A
(en)
*
|
2003-03-01 |
2005-01-01 |
Astrazeneca Ab |
Hydroxymethyl compounds
|
|
US20040191326A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Reo Joseph P. |
Taste-masking vehicle for coated oxazolidinone particles
|
|
US20040204463A1
(en)
*
|
2003-04-01 |
2004-10-14 |
Harris Christina Renee |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
|
KR101101982B1
(ko)
|
2003-04-30 |
2012-01-02 |
모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 |
옥사졸리디논-퀴놀린 하이브리드 항생제의 탄저병 및 기타감염증의 치료용의 용도
|
|
US8324398B2
(en)
|
2003-06-03 |
2012-12-04 |
Rib-X Pharmaceuticals, Inc. |
Process for the synthesis of biaryl oxazolidinones
|
|
PT1656370E
(pt)
|
2003-06-03 |
2012-11-29 |
Rib X Pharmaceuticals Inc |
Compostos biaril-heterocíclicos e métodos de os produzir e de os utilizar
|
|
CA2529294A1
(en)
*
|
2003-07-02 |
2005-01-20 |
Merck & Co., Inc. |
Oxazolidinone antibiotics and derivatives thereof
|
|
AU2004256085B2
(en)
*
|
2003-07-02 |
2007-12-06 |
Kyorin, Pharmaceutical Co., Ltd. |
Cyclopropyl Group Substituted Oxazolydinone Antibiotics and Derivatives Thereof
|
|
ATE471937T1
(de)
*
|
2003-07-02 |
2010-07-15 |
Merck Sharp & Dohme |
Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
|
|
US20060247286A1
(en)
*
|
2003-07-02 |
2006-11-02 |
Milton Hammond |
Oxazolidinone antibiotics and derivatives thereof
|
|
JP2007503426A
(ja)
*
|
2003-08-25 |
2007-02-22 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
新規な抗微生物性アリールオキサゾリジノン化合物
|
|
DE10340485B4
(de)
|
2003-09-03 |
2015-05-13 |
Morphochem AG Aktiengesellschaft für kombinatorische Chemie |
Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
|
|
US7304050B2
(en)
*
|
2003-09-16 |
2007-12-04 |
Pfizer Inc. |
Antibacterial agents
|
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
|
TW200526649A
(en)
|
2003-12-17 |
2005-08-16 |
Rib X Pharmaceuticals Inc |
Halogenated biaryl heterocyclic compounds and methods of making and using the same
|
|
US8158797B2
(en)
|
2003-12-18 |
2012-04-17 |
Morphochem Aktiengesellschaft Fur Kombinatorische Chemie |
Oxazolidinone-quinolone hybrid antibiotics
|
|
ATE401326T1
(de)
|
2003-12-18 |
2008-08-15 |
Morphochem Ag Komb Chemie |
Oxazolidinon-chinolon hybrid antibiotika
|
|
KR100854211B1
(ko)
|
2003-12-18 |
2008-08-26 |
동아제약주식회사 |
신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
|
|
JP2008508271A
(ja)
*
|
2004-07-28 |
2008-03-21 |
リブ−エックス ファーマシューティカルズ,インコーポレイテッド |
ビアリール複素環式化合物ならびにその化合物を製造および使用する方法
|
|
WO2006018682A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
|
AU2005286593A1
(en)
*
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyridine compounds, process for their preparation and compositions containing them
|
|
CN101065397B
(zh)
|
2004-09-28 |
2015-10-21 |
詹森药业有限公司 |
一种细菌atp合酶的结合结构域
|
|
EP1799677A1
(de)
*
|
2004-10-08 |
2007-06-27 |
Ranbaxy Laboratories Limited |
Oxazolidinon-derivate mit antimikrobieller funktion
|
|
DE102004062475A1
(de)
*
|
2004-12-24 |
2006-07-06 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
|
|
EP1685841A1
(de)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prophylaxe und Behandlung von thrombolischen Erkrankungen
|
|
EP1866295A2
(de)
|
2005-02-24 |
2007-12-19 |
Teva Pharmaceutical Industries Ltd |
Verfahren zur herstellung von linezolidzwischenprodukten
|
|
EP1874782A1
(de)
|
2005-04-15 |
2008-01-09 |
Ranbaxy Laboratories Limited |
Oxazolidinon-derivate als antimikrobielle mittel
|
|
DE602006019870D1
(de)
|
2005-06-08 |
2011-03-10 |
Rib X Pharmaceuticals Inc |
Verfahren zur synthese von triazolen
|
|
DE102005045518A1
(de)
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
|
DE102005047558A1
(de)
*
|
2005-10-04 |
2008-02-07 |
Bayer Healthcare Ag |
Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
|
|
CA2823159C
(en)
|
2005-10-04 |
2014-10-21 |
Bayer Intellectual Property Gmbh |
Polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
|
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
|
DE102005048824A1
(de)
*
|
2005-10-10 |
2007-04-12 |
Bayer Healthcare Ag |
Behandlung und Prophylaxe von Mikroangiopathien
|
|
WO2007133803A2
(en)
*
|
2006-05-15 |
2007-11-22 |
Rib-X Pharmaceuticals, Inc. |
Treatment of mycobacterial infections
|
|
DE102006051625A1
(de)
*
|
2006-11-02 |
2008-05-08 |
Bayer Materialscience Ag |
Kombinationstherapie substituierter Oxazolidinone
|
|
DE102007018662A1
(de)
|
2007-04-20 |
2008-10-23 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie
|
|
DE102007028318A1
(de)
|
2007-06-20 |
2008-12-24 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von Sepsis
|
|
JP2011506363A
(ja)
*
|
2007-12-11 |
2011-03-03 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
心不全の処置および/または予防用のオキサゾリジノン類
|
|
US8575337B2
(en)
|
2008-06-24 |
2013-11-05 |
Research Foundation Itsuu Laboratory |
Oxazolidinone derivative having fused ring
|
|
EP2138178A1
(de)
|
2008-06-28 |
2009-12-30 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidninone zur Behandlung der chronisch obstruktiven Lungenerkrankung (COPD) und/oder Asthma
|
|
EP2140866A1
(de)
*
|
2008-07-04 |
2010-01-06 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidinone zur Behandlung von Entzündungserkrankungen des Magen-Darm-Trakts
|
|
MX2011003820A
(es)
|
2008-10-10 |
2011-06-16 |
Trius Therapeutics |
Metodos para preparar oxazolidinonas y composiciones que las contienen.
|
|
KR20110092309A
(ko)
|
2008-11-20 |
2011-08-17 |
파나세아 바이오테크 리미티드 |
신규 항균제
|
|
SG173497A1
(en)
|
2009-02-03 |
2011-09-29 |
Trius Therapeutics |
Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
|
|
US8580767B2
(en)
|
2009-05-28 |
2013-11-12 |
Trius Therapeutics, Inc. |
Oxazolidinone containing dimer compounds, compositions and methods to make and use
|
|
CA2765692A1
(en)
|
2009-06-26 |
2010-12-29 |
Panacea Biotec Ltd. |
Novel azabicyclohexanes
|
|
EP2496563A4
(de)
*
|
2009-11-04 |
2013-04-03 |
Sichuan Beilike Biotechnology Ltd Liability Company |
Bestimmte kristalline hydrate, pharmazeutische zusammensetzungen damit und verfahren zu ihrer herstellung und verwendung
|
|
CN102153547A
(zh)
*
|
2010-02-11 |
2011-08-17 |
山东轩竹医药科技有限公司 |
含有并环的噁唑烷酮抗菌素
|
|
CN102276595A
(zh)
*
|
2010-04-16 |
2011-12-14 |
山东轩竹医药科技有限公司 |
含有五元杂环的噁唑烷酮抗菌素
|
|
EP2969004B1
(de)
|
2013-03-15 |
2026-02-25 |
Melinta Subsidiary Corp. |
Delafloxacin zur verwending in der behandlung von infektionen bei adipösen patienten
|
|
CN104356124A
(zh)
*
|
2014-10-30 |
2015-02-18 |
广东东阳光药业有限公司 |
噁唑烷酮类化合物及其组合物和用途
|
|
AU2015346023A1
(en)
|
2014-11-14 |
2017-06-01 |
Melinta Subsidiary Corp. |
Method for treating, preventing, or reducing the risk of skin infection
|
|
CN104447730B
(zh)
*
|
2014-12-05 |
2017-11-07 |
广东东阳光药业有限公司 |
噁唑烷酮类化合物及其在药物中的应用
|
|
KR101660874B1
(ko)
|
2015-09-04 |
2016-09-30 |
주식회사 알에스텍 |
리네졸리드의 제조방법 및 그 중간체
|
|
WO2017066964A1
(en)
|
2015-10-22 |
2017-04-27 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compounds and methods of use thereof as antibacterial agents
|
|
WO2021184339A1
(en)
|
2020-03-20 |
2021-09-23 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compound and methods of use thereof as an antibacterial agent
|